• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罗马 IV 型肠易激综合征对工作和日常生活活动的影响。

Impact of Rome IV irritable bowel syndrome on work and activities of daily living.

机构信息

Leeds Institute of Medical Research at St. James's, University of Leeds, Leeds, UK.

Leeds Gastroenterology Institute, St. James's University Hospital, Leeds, UK.

出版信息

Aliment Pharmacol Ther. 2022 Sep;56(5):844-856. doi: 10.1111/apt.17132. Epub 2022 Jul 6.

DOI:10.1111/apt.17132
PMID:35794733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9543519/
Abstract

BACKGROUND

Few studies have demonstrated the impact of irritable bowel syndrome (IBS) on work and activities of daily living.

METHODS

We collected demographic, gastrointestinal symptom, psychological health and quality of life data from 752 adults with Rome IV-defined IBS. We used the work productivity and activity impairment questionnaire for irritable bowel syndrome and the work and social adjustment scale to examine the degree of both impairment at work and in activities of daily living, as well as factors associated with these.

RESULTS

Of 467 individuals who were employed, 133 (28.5%) reported absenteeism, 373 (85.6%) presenteeism and 382 (81.8%) overall work impairment. A mean of 1.97 hours of work per week was lost due to IBS. Extrapolating this across the entire UK, we estimate that between 72 and 188 million hours of work are lost per year due to IBS in individuals of working age. Among all 752 participants, 684 (91.0%) reported any activity impairment with 220 (29.3%) reporting impairment in home management, 423 (56.3%) in social leisure activities, 207 (27.5%) in private leisure activities, and 203 (27.0%) in maintaining close relationships. Severe IBS, higher levels of anxiety, depression, somatization and gastrointestinal symptom-specific anxiety, and lower levels of IBS-related quality of life were associated with impairment in both work and activities of daily living.

CONCLUSION

Patients with IBS experience a substantial impact on their work and activities of daily living because of their IBS. Future studies should assess the impact of medical interventions on the ability to work and participate in social activities.

摘要

背景

很少有研究表明肠易激综合征(IBS)对工作和日常生活活动的影响。

方法

我们从 752 名符合罗马 IV 标准的 IBS 成人中收集了人口统计学、胃肠道症状、心理健康和生活质量数据。我们使用肠易激综合征工作生产力和活动障碍问卷以及工作和社会调整量表来检查工作和日常生活活动中障碍的程度,以及与这些相关的因素。

结果

在 467 名就业的个体中,133 名(28.5%)报告缺勤,373 名(85.6%)存在在职现象,382 名(81.8%)整体工作障碍。每周因 IBS 损失平均 1.97 小时的工作时间。根据这个数据在整个英国进行推断,我们估计每年因工作年龄个体的 IBS 导致 7200 万至 1.88 亿小时的工作时间损失。在所有 752 名参与者中,684 名(91.0%)报告存在任何活动障碍,其中 220 名(29.3%)报告在家庭管理方面存在障碍,423 名(56.3%)在社会休闲活动方面存在障碍,207 名(27.5%)在私人休闲活动方面存在障碍,203 名(27.0%)在维持亲密关系方面存在障碍。严重的 IBS、更高的焦虑、抑郁、躯体化和胃肠道症状特异性焦虑水平,以及更低的 IBS 相关生活质量与工作和日常生活活动障碍有关。

结论

IBS 患者因 IBS 而对工作和日常生活活动产生了重大影响。未来的研究应该评估医疗干预对工作能力和参与社会活动能力的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b00/9543519/2cfbbd9aa24b/APT-56-844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b00/9543519/353a55f22c45/APT-56-844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b00/9543519/2cfbbd9aa24b/APT-56-844-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b00/9543519/353a55f22c45/APT-56-844-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b00/9543519/2cfbbd9aa24b/APT-56-844-g001.jpg

相似文献

1
Impact of Rome IV irritable bowel syndrome on work and activities of daily living.罗马 IV 型肠易激综合征对工作和日常生活活动的影响。
Aliment Pharmacol Ther. 2022 Sep;56(5):844-856. doi: 10.1111/apt.17132. Epub 2022 Jul 6.
2
Factors associated with lower disease-specific and generic health-related quality of life in Rome IV irritable bowel syndrome.罗马IV型肠易激综合征中与较低疾病特异性和一般健康相关生活质量相关的因素。
Aliment Pharmacol Ther. 2023 Feb;57(3):323-334. doi: 10.1111/apt.17356. Epub 2022 Dec 21.
3
Prevalence and impact of faecal incontinence among individuals with Rome IV irritable bowel syndrome.罗马 IV 型肠易激综合征患者粪便失禁的流行情况及其影响。
Aliment Pharmacol Ther. 2023 May;57(10):1083-1092. doi: 10.1111/apt.17465. Epub 2023 Mar 13.
4
Health-related quality of life, work productivity, and indirect costs among patients with irritable bowel syndrome with diarrhea.腹泻型肠易激综合征患者的健康相关生活质量、工作效率及间接成本
Health Qual Life Outcomes. 2017 Feb 14;15(1):35. doi: 10.1186/s12955-017-0611-2.
5
Utility of irritable bowel syndrome subtypes and most troublesome symptom in predicting disease impact and burden.肠易激综合征亚型和最困扰症状的实用性在预测疾病影响和负担方面。
Neurogastroenterol Motil. 2024 Apr;36(4):e14756. doi: 10.1111/nmo.14756. Epub 2024 Feb 6.
6
The impact of irritable bowel syndrome on daily functioning: Characterizing and understanding daily consequences of IBS.肠易激综合征对日常功能的影响:描述和理解肠易激综合征的日常后果。
Neurogastroenterol Motil. 2017 Apr;29(4). doi: 10.1111/nmo.12982. Epub 2016 Oct 25.
7
Work Productivity and Activity Impairment in Irritable Bowel Syndrome (IBS): A Multifaceted Problem.肠易激综合征(IBS)患者的工作效率和活动能力受损:一个多方面的问题。
Am J Gastroenterol. 2018 Oct;113(10):1540-1549. doi: 10.1038/s41395-018-0262-x. Epub 2018 Sep 25.
8
Novel Symptom Subgroups in Individuals With Irritable Bowel Syndrome Predict Disease Impact and Burden.肠易激综合征患者的新型症状亚组可预测疾病影响和负担。
Clin Gastroenterol Hepatol. 2024 Feb;22(2):386-396.e10. doi: 10.1016/j.cgh.2023.02.016. Epub 2023 Feb 27.
9
Natural History and Disease Impact of Rome IV Vs Rome III Irritable Bowel Syndrome: A Longitudinal Follow-Up Study.罗马IV型与罗马III型肠易激综合征的自然史及疾病影响:一项纵向随访研究
Clin Gastroenterol Hepatol. 2022 Mar;20(3):569-577.e3. doi: 10.1016/j.cgh.2021.04.043. Epub 2021 May 3.
10
Prevalence and impact of Rome IV versus Rome III irritable bowel syndrome in patients with inflammatory bowel disease.罗马 IV 标准与罗马 III 标准诊断炎症性肠病患者肠易激综合征的流行率和影响。
Neurogastroenterol Motil. 2022 May;34(5):e14256. doi: 10.1111/nmo.14256. Epub 2021 Sep 1.

引用本文的文献

1
Common misconceptions and controversies in the management of irritable bowel syndrome.肠易激综合征管理中的常见误解与争议
Nat Rev Gastroenterol Hepatol. 2025 Apr 25. doi: 10.1038/s41575-025-01065-9.
2
Effect of DSW3805 Isolated from Kimchi for Gut Health Attenuating Colonic Inflammation in a Dextran Sulfate Sodium-Induced Mouse Model.从泡菜中分离出的DSW3805对肠道健康的影响:在葡聚糖硫酸钠诱导的小鼠模型中减轻结肠炎症
Nutrients. 2025 Apr 3;17(7):1259. doi: 10.3390/nu17071259.
3
Could the Therapeutic Effect of Physical Activity on Irritable Bowel Syndrome Be Mediated Through Changes to the Gut Microbiome? A Narrative and Hypothesis Generating Review.

本文引用的文献

1
Direct healthcare costs of Rome IV or Rome III-defined irritable bowel syndrome in the United Kingdom.英国罗马 IV 或罗马 III 定义的肠易激综合征的直接医疗成本。
Aliment Pharmacol Ther. 2022 Jul;56(1):110-120. doi: 10.1111/apt.16939. Epub 2022 May 1.
2
Maintaining work life under threat of symptoms: a grounded theory study of work life experiences in persons with Irritable Bowel Syndrome.在症状威胁下维持工作生活:肠易激综合征患者工作生活体验的扎根理论研究。
BMC Gastroenterol. 2022 Feb 19;22(1):73. doi: 10.1186/s12876-022-02158-4.
3
Willingness to accept risk with medication in return for cure of symptoms among patients with Rome IV irritable bowel syndrome.
体育活动对肠易激综合征的治疗作用是否可通过肠道微生物群的变化介导?一项叙述性及提出假设的综述
Neurogastroenterol Motil. 2025 Jun;37(6):e70004. doi: 10.1111/nmo.70004. Epub 2025 Mar 3.
4
Self-administered active versus sham acupressure for diarrhea predominant irritable bowel syndrome: a nurse-led randomized clinical trial.自我实施的主动与假穴位按压治疗腹泻型肠易激综合征:一项由护士主导的随机临床试验。
BMC Nurs. 2025 Jan 28;24(1):106. doi: 10.1186/s12912-024-02594-5.
5
Predictors of response to low-dose amitriptyline for irritable bowel syndrome and efficacy and tolerability according to subtype: post hoc analyses from the ATLANTIS trial.根据亚型分析低剂量阿米替林治疗肠易激综合征的反应预测因素、疗效及耐受性:ATLANTIS试验的事后分析
Gut. 2025 Apr 7;74(5):728-739. doi: 10.1136/gutjnl-2024-334490.
6
The Role of Gut Microbiome in Irritable Bowel Syndrome: Implications for Clinical Therapeutics.肠道微生物群在肠易激综合征中的作用:对临床治疗的启示
Biomolecules. 2024 Dec 21;14(12):1643. doi: 10.3390/biom14121643.
7
A Pilot Study of the Effectiveness of a Short Course of Rifaximin 2200 mg/day on Abdominal Symptoms and its Effects on Quality of Life in Patients with Moderate to Severe Diarrhea-Predominant Irritable Bowel Syndrome.利福昔明 2200mg/天短期疗程治疗中重度腹泻型肠易激综合征的有效性及其对生活质量影响的初步研究。
Clin Drug Investig. 2024 Nov;44(11):839-847. doi: 10.1007/s40261-024-01403-w. Epub 2024 Oct 30.
8
Effect of Personalized Prebiotic and Probiotic Supplements on the Symptoms of Irritable Bowel Syndrome: An Open-Label, Single-Arm, Multicenter Clinical Trial.个性化益生元和益生菌补充剂对肠易激综合征症状的影响:一项开放标签、单臂、多中心临床试验。
Nutrients. 2024 Oct 1;16(19):3333. doi: 10.3390/nu16193333.
9
Low-dose titrated amitriptyline as second-line treatment for adults with irritable bowel syndrome in primary care: the ATLANTIS RCT.低剂量滴定阿米替林作为一线治疗对初级保健中成人肠易激综合征的二线治疗:ATLANTIS RCT。
Health Technol Assess. 2024 Oct;28(66):1-161. doi: 10.3310/BFCR7986.
10
Effects of Physical Exercise on the Microbiota in Irritable Bowel Syndrome.运动锻炼对肠易激综合征患者肠道微生物群的影响。
Nutrients. 2024 Aug 11;16(16):2657. doi: 10.3390/nu16162657.
罗马 IV 型肠易激综合征患者为治愈症状愿意接受药物治疗风险。
Aliment Pharmacol Ther. 2022 May;55(10):1311-1319. doi: 10.1111/apt.16816. Epub 2022 Feb 15.
4
Efficacy of a low FODMAP diet in irritable bowel syndrome: systematic review and network meta-analysis.低 FODMAP 饮食对肠易激综合征的疗效:系统评价和网络荟萃分析。
Gut. 2022 Jun;71(6):1117-1126. doi: 10.1136/gutjnl-2021-325214. Epub 2021 Aug 10.
5
A Review of the Evidence and Recommendations on Communication Skills and the Patient-Provider Relationship: A Rome Foundation Working Team Report.证据回顾与沟通技巧及医患关系的建议:罗马基金会工作组报告。
Gastroenterology. 2021 Nov;161(5):1670-1688.e7. doi: 10.1053/j.gastro.2021.07.037. Epub 2021 Jul 28.
6
British Society of Gastroenterology guidelines on the management of irritable bowel syndrome.英国胃肠病学会关于肠易激综合征管理的指南。
Gut. 2021 Jul;70(7):1214-1240. doi: 10.1136/gutjnl-2021-324598. Epub 2021 Apr 26.
7
Impact of Psychological Comorbidity on the Prognosis of Irritable Bowel Syndrome.心理共病对肠易激综合征预后的影响。
Am J Gastroenterol. 2021 Jul 1;116(7):1485-1494. doi: 10.14309/ajg.0000000000001247.
8
Longitudinal follow-up of a novel classification system for irritable bowel syndrome: natural history and prognostic value.肠易激综合征新型分类系统的纵向随访:自然史和预后价值。
Aliment Pharmacol Ther. 2021 May;53(10):1126-1137. doi: 10.1111/apt.16322. Epub 2021 Mar 11.
9
Pharmacologic, Dietary, and Psychological Treatments for Irritable Bowel Syndrome With Constipation: Cost Utility Analysis.便秘型肠易激综合征的药物、饮食及心理治疗:成本效用分析
MDM Policy Pract. 2021 Jan 18;6(1):2381468320978417. doi: 10.1177/2381468320978417. eCollection 2021 Jan-Jun.
10
Functional gastrointestinal disorders: advances in understanding and management.功能性胃肠病:理解和治疗方面的进展。
Lancet. 2020 Nov 21;396(10263):1664-1674. doi: 10.1016/S0140-6736(20)32115-2. Epub 2020 Oct 10.